Obsidian Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor infiltrating lymphocytes (TIL) cell therapies for the treatment of patients with solid tumors... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XOVL | 22.51 | 0.64 | +2.95% |
| Defiance Daily Target 2X Long XOVR ETF (XOVL) | |||
| VCRM | 71.59 | 0.34 | +0.48% |
| Vanguard Core Tax-Exempt Bond ETF (VCRM) | |||
| MUSE | 48.10 | 0.18 | +0.37% |
| TCW Multisector Credit Income ETF (MUSE) | |||
| DFNL | 48.67 | 0.10 | +0.21% |
| Davis Select Financial ETF (DFNL) | |||
| DRES | 28.56 | 0.01 | +0.03% |
| GMO Domestic Resilience ETF (DRES) | |||
Industry Biotechnology